Overactivation of calcineurin induced by amyloid-beta and prion proteins

Neurochemistry International

Volumn 52, Issue 6, 2008, Pages 1226-1233

  Agostinho, Paula ^a,b   Lopes, João P ^a   Velez, Zélia ^a   Oliveira, Catarina R ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Amyloid beta; BAD; Calcineurin; Neurotoxicity; Prion protein

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[25-35]; BRAIN PROTEIN; CALCINEURIN; CALCINEURIN INHIBITOR; CYTOCHROME C; MITOCHONDRIAL ENZYME; PHOSPHOPROTEIN PHOSPHATASE; PRION PROTEIN; PRION PROTEIN 106-126; PROTEIN BAD; SERINE; TACROLIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; CELL CULTURE; CONTROLLED STUDY; CYTOSOLIC FRACTION; EMBRYO; ENZYME ACTIVITY; ENZYME RELEASE; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEIN TRANSPORT; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; BRAIN; CALCINEURIN; CELLS, CULTURED; CYTOCHROMES C; ENZYME ACTIVATION; MITOCHONDRIA; NERVE DEGENERATION; NEURONS; PEPTIDES; PRION DISEASES; PROTEIN TRANSPORT; PRPSC PROTEINS; RATS; RATS, WISTAR;

RATTUS;

EID: 40949104298     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.01.005     Document Type: Article

References (31)

1. Agostinho P., and Oliveira C.R. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur. J. Neurosci. 17 (2003) 1189-1196
2. Aguzzi A., and Haass C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 302 (2003) 814-818
3. Barnham K.J., Cappai R., Beyreuther K., Masters C.L., and Hill A.F. Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem. Sci. 31 (2006) 465-472
4. Biasini E., Massignan T., Fioriti L., Rossi V., Dossena S., Salmona M., Forloni G., Bonetto V., and Chiesa R. Analysis of the cerebellar proteome in a transgenic mouse model of inherited prion disease reveals preclinical alteration of calcineurin activity. Proteomics 6 (2006) 2823-2834
5. Bultynck G., Vermassen E., Szlufcik K., De Smet P., Fissore R.A., Callewaert G., Missiaen L., De Smedt H., and Parys J.B. Calcineurin and intracellular Ca2+-release channels: regulation or association?. Biochem. Biophys. Res. Commun. 311 (2003) 1181-1193
6. Burley J.R., and Sihra T.S. A modulatory role for protein phosphatase 2B (calcineurin) in the regulation of Ca2+ entry. Eur. J. Neurosci. 12 (2000) 2881-2891
7. Cardoso S.M., and Oliveira C.R. The role of calcineurin in amyloid-beta-peptides-mediated cell death. Brain Res. 1050 (2005) 1-7
8. Carter C.J. Convergence of genes implicated in Alzheimer's disease on the cerebral cholesterol shuttle: APP, cholesterol, lipoproteins, and atherosclerosis. Neurochem. Int. 50 (2007) 12-38
9. Celsi F., Svedberg M., Unger C., Cotman C.W., Carri M.T., Ottersen O.P., Nordberg A., and Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol. Dis. 26 (2007) 342-352
10. Cobb N.J., Sönnichsen F.D., McHaourab H., and Surewicz W.K. Molecular architecture of human prion protein amyloid: a parallel, in-register beta-structure. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 8946-8951
11. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
12. Dineley K.T., Hogan D., Zhang W.R., and Taglialatela G. Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol. Learn. Mem. 88 (2007) 217-224
13. Ferreiro E., Resende R., Costa R., Oliveira C.R., and Pereira C.M. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol. Dis. 23 (2006) 669-678
14. Hara M.R., and Snyder S.H. Cell signaling and neuronal death. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 117-141
15. Hur K., Kim J.I., Choi S.I., Choi E.K., Carp R.I., and Kim Y.S. The pathogenic mechanisms of prion diseases. Mech. Ageing Dev. 123 (2002) 1637-1647
16. Kawahara M. Disruption of calcium homeostasis in the pathogenesis of Alzheimer's disease and other conformational diseases. Curr. Alzheimer Res. 1 (2004) 87-95
17. Kim H., Rafiuddin-Shah M., Tu H.C., Jeffers J.R., Zambetti G.P., Hsieh J.J., and Cheng E.H. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8 (2006) 1348-1358
18. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 3 (2002) 862-872
19. Liu F., Grundke-Iqbal I., Iqbal K., Oda Y., Tomizawa K., and Gong C.X. Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J. Biol. Chem. 280 (2005) 37755-37762
20. Mansuy I.M. Calcineurin in memory and bidirectional plasticity. Biochem. Biophys. Res. Commun. 311 (2003) 1195-1208
21. Marks N., and Berg M.J. Neurosecretases provide strategies to treat sporadic and familial Alzheimer disorders. Neurochem. Int. 52 (2008) 184-215
22. Mattson M.P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid. Redox. Signal. 8 (2006) 1997-2006
23. Morgan D. Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice. Neurochem. Int. 49 (2006) 190-194
24. Norris C.M., Kadish I., Blalock E.M., Chen K.C., Thibault V., Porter N.M., Landfield P.W., and Kraner S.D. Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J. Neurosci. 25 (2005) 4649-4658
25. Pong K., and Zaleska M.M. Therapeutic implications for immunophilin ligands in the treatment of neurodegenerative diseases. Curr. Drug Targets CNS Neurol. Disord. 2 (2003) 349-356
26. Snyder S.H., Lai M.M., and Burnett P.E. Immunophilins in the nervous system. Neuron 21 (1998) 283-294
27. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
28. Soto C. Alzheimer's and prion disease as disorders of protein conformation: implications for the design of novel therapeutic approaches. J. Mol. Med. 77 (1999) 412-418
29. Springer J.E., Azbill R.D., Nottingham S.A., and Kennedy S.E. Calcineurin-mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci. 20 (2000) 7246-7251
30. Wang H.G., Pathan N., Ethell I.M., Krajewski S., Yamaguchi Y., Shibasaki F., McKeon F., Bobo T., Franke T.F., and Reed J.C. Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science 284 (1999) 339-343
31. Wisniewski T., and Sigurdsson E.M. Therapeutic approaches for prion and Alzheimer's diseases. FEBS J. 274 (2007) 3784-3798